Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen
The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subj...
Saved in:
Published in | The Journal of pharmacology and experimental therapeutics Vol. 272; no. 2; pp. 758 - 765 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.02.1995
American Society for Pharmacology and Experimental Therapeutics |
Subjects | |
Online Access | Get full text |
ISSN | 0022-3565 1521-0103 |
DOI | 10.1016/S0022-3565(25)24478-0 |
Cover
Loading…
Abstract | The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation. |
---|---|
AbstractList | The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation. The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation. The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation.The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model development because it is firmly established as a pruritogen in both conjunctiva and skin. Itching evokes the desire to scratch in human subjects, so hind limb scratching at the afflicted area was used to identify pruritogenic stimuli. Under optimized environmental conditions, hind limb scratching behavior yielded substantial and highly reproducible responses. The conjunctival itch-scratch response was delineated from pain and foreign body sensations by using appropriate stimuli. Examination of a large and diverse variety of autocoids revealed that only histamine, platelet-activating factor (PAF) and arachidonic acid and its cyclooxygenase metabolite prostaglandin E2 possessed meaningful pruritogenic activity. PAF-induced ocular pruritus did not involve histamine release, according to studies with appropriate antagonists. Thus PAF-induced ocular pruritus was unaffected by the histamine H1-receptor antagonist pyrilamine but was substantially attenuated by the PAF antagonists WEB 2086 and CV-6209 and was virtually abolished by E-6123. Similar itch-scratch behaviors were quantified in hairless guinea pig skin following the application of cowhage or the iontophoretic administration of histamine and PAF. Findings from these newly developed itching models suggest that PAF could be an important mediator of the pruritic sensation by activating a population of nerve endings responsible for encoding the itch sensation. |
Author | Nieves, A L Woodward, D F Spada, C S Tuckett, R P Williams, L S |
Author_xml | – sequence: 1 givenname: D F surname: Woodward fullname: Woodward, D F – sequence: 2 givenname: A L surname: Nieves fullname: Nieves, A L – sequence: 3 givenname: C S surname: Spada fullname: Spada, C S – sequence: 4 givenname: L S surname: Williams fullname: Williams, L S – sequence: 5 givenname: R P surname: Tuckett fullname: Tuckett, R P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7853191$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUcFu1DAUtFBR2RY-oZJPCA4B27GdVBwQWtGCVIkDcLZenJfEkMTBdhYtB74db3fhwKWSJfv5zYyfZy7I2exnJOSKs1eccf36M2NCFKXS6oVQL4WUVV2wR2TDleAF46w8I5t_kCfkIsZvjHEpdXlOzqtalfyab8jv7QABbMLgfkFyfqa-o0AbHGDnfICRTr7FkXY-0CWDlgHz5binuPPfsaUu2YHGte8xpkiXERKOmIqs6HZZb-5pl8-ZDDHLLj7hnOgS1uCS73F-Sh53MEZ8dtovydeb91-2H4q7T7cft-_uCitVlYrrDrHUus5FjSVyAGikxVqyRnCUdQPQCZ3_pLSWQugGOwCmLWs1olJYXpLnR90l-B9rntVMLlocR5jRr9FUFZe8ZDIDr07AtZmwNUtwE4S9ORmW-2-OfRt8jAE7Y126Ny4FcKPhzBzSMffpmIP1RuR1SMewzFb_sf_qP8Q7jT-4fvjpApolxzaB9aPv90ZUwghTqToD3x6BmM3cOQwmWoezxTaTbDKtdw889QdlDrdH |
CitedBy_id | crossref_primary_10_1089_jop_1995_11_339 crossref_primary_10_1254_fpj_135_134 crossref_primary_10_1152_jn_00302_2011 crossref_primary_10_1152_jn_00938_2009 |
ContentType | Journal Article |
Copyright | 1995 American Society for Pharmacology and Experimental Therapeutics |
Copyright_xml | – notice: 1995 American Society for Pharmacology and Experimental Therapeutics |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/S0022-3565(25)24478-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1521-0103 |
EndPage | 765 |
ExternalDocumentID | 7853191 10_1016_S0022_3565_25_24478_0 272_2_758 S0022356525244780 |
Genre | Journal Article |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 8WZ A6W AAJMC AALRI AAXUO AAYOK ABCQX ABIVO ABJNI ABOCM ABSQV ACGFO ACGFS ACNCT ADBBV ADCOW ADIYS AENEX AERNN AFFNX AFHIN AFOSN AGFXO AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD F5P F9R FDB GX1 H13 HZ~ INIJC KQ8 L7B LSO M41 MJL MVM O9- OHT OK1 P2P R.V R0Z RHF RHI RPT TR2 UQL VH1 W2D W8F WH7 WOQ X7M YBU YHG YQT ZGI ZXP - 08R 0R 55 8RP AALRV ABFLS ABSGY ABZEH ADBIT ADKFC AETEA AIKQT DL FH7 GJ HZ X AAYXX ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP CITATION ROL CGR CUY CVF ECM EIF NPM PKN 7X8 |
ID | FETCH-LOGICAL-c457t-9fee36684578e3e1aaab4ce840b21e48baaf268535664226befaa06c0d6ee55e3 |
ISSN | 0022-3565 |
IngestDate | Fri Sep 05 07:48:24 EDT 2025 Wed Feb 19 01:21:51 EST 2025 Tue Jul 01 05:29:27 EDT 2025 Thu Apr 24 22:53:36 EDT 2025 Tue Jan 05 21:17:55 EST 2021 Sat Feb 01 16:08:06 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c457t-9fee36684578e3e1aaab4ce840b21e48baaf268535664226befaa06c0d6ee55e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 7853191 |
PQID | 77141304 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_77141304 pubmed_primary_7853191 crossref_citationtrail_10_1016_S0022_3565_25_24478_0 crossref_primary_10_1016_S0022_3565_25_24478_0 highwire_pharmacology_272_2_758 elsevier_sciencedirect_doi_10_1016_S0022_3565_25_24478_0 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1995-02-01 |
PublicationDateYYYYMMDD | 1995-02-01 |
PublicationDate_xml | – month: 02 year: 1995 text: 1995-02-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of pharmacology and experimental therapeutics |
PublicationTitleAlternate | J Pharmacol Exp Ther |
PublicationYear | 1995 |
Publisher | Elsevier Inc American Society for Pharmacology and Experimental Therapeutics |
Publisher_xml | – name: Elsevier Inc – name: American Society for Pharmacology and Experimental Therapeutics |
SSID | ssj0014463 |
Score | 1.6915617 |
Snippet | The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model... The studies described herein characterize animal behavioral models for conjunctival and cutaneous itch. Histamine was used as the reference stimulus for model... |
SourceID | proquest pubmed crossref highwire elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 758 |
SubjectTerms | Animals Azepines - pharmacology Female Guinea Pigs Histamine - pharmacology Male Platelet Activating Factor - analogs & derivatives Platelet Activating Factor - pharmacology Pruritus - chemically induced Pyridinium Compounds - pharmacology Triazoles - pharmacology |
Title | Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen |
URI | https://dx.doi.org/10.1016/S0022-3565(25)24478-0 http://jpet.aspetjournals.org/content/272/2/758.abstract https://www.ncbi.nlm.nih.gov/pubmed/7853191 https://www.proquest.com/docview/77141304 |
Volume | 272 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtx6BQxm5l2VUPa9lwndnyNY8jtJTRjUFTljch23JhS2PTOIX2Yb9951i2pGUt2QbBJCZyDvm-c3QknQshb_M0kn7hj1yWxrBASZPCzbzSg3cZTkhxwtq6BZ-_xMdn4adpNN3Y3LGilpZNNsxvbs0r-R9U4R7gilmy_4CsfijcgPeAL1wBYbj-FcZjXW35Rnt-ws68b_vctJGEWNC4rSAwm1078qr6IfHMIMfw9HM8YlpgP-kG5qDGxVQH3KjFEMu2Gw_2ohFOXTUYN1BfYr-76rxLIftu2Gb5trUpiK3qO_3WSMDK-TJt7Z0j51tVtS2kNQmdE2CqvDJhjmPn1DmthdlFOIEb_ZaR2cDoE8LtYJD-ZMoOU_26KuahLeZkVUw7MUG1nhjKzp4z3C3xAtvgs4RZzGaW-U5UGfk_phW1w7HQv7CHGb97DNauIRYotscAQ-qLlm9JivbNNxNtH1ywMv_qqEiQizMOMmySewxWPW0nkqmOWMKVe6CL34MUJiHtgxHtHYved2Jtk_udDHc5Xbom9t3rq9bPmjwkDzoS0Y-K7Y_Ihpw_JvsdUtcH1EblgO5TG8Mn5OeqStCqpIIalaCtSlBAn9oqQZVKUFQJ2qsEvUUlqFIJKhbwWKUS1KjEU3J2dDgZH7tdixE3D6OkcUellEEcp_AhlYH0hRBZmMs09DLmSzBYQpQshj8RVj2Yc57JUggvzr0iljKKZLBLtubVXD4jFFxpURYRG6VxECZZBCuxAuxj5otiFHtpMSBhjwHPu_r72AZmxk2gJYDIEUTO4IUgcm9AhnpYrQrQrBuQ9gDzzotW3jEHNq8b-qYnBLcNBdfMhG_0POEwD-HhopjLarngSeKjPxwOyK6ij5a24-DztQ9_QbaNfXhJtprLpXwFLn-TvW4V4ReREAOC |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+a+behavioral+model+for+peripherally+evoked+itch+suggests+platelet-activating+factor+as+a+potent+pruritogen&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=D+F+Woodward&rft.au=A+L+Nieves&rft.au=C+S+Spada&rft.au=L+S+Williams&rft.date=1995-02-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=272&rft.issue=2&rft.spage=758&rft_id=info:doi/10.1016%2Fs0022-3565%2825%2924478-0&rft_id=info%3Apmid%2F7853191&rft.externalDBID=n%2Fa&rft.externalDocID=272_2_758 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon |